C07D 213/81
Amides
Official title: Amides; Imides
C07D213/81 (Amides) appears on 3,105 US grants and 3,155 published applications in this corpus.
Search patents in C07D- Granted patents
- 3,105
- Published applications
- 3,155
- Assignees
- 1,242
- Inventors
- 9,591
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 31 | 0 |
| 1977 | 39 | 0 |
| 1978 | 32 | 0 |
| 1979 | 24 | 0 |
| 1980 | 24 | 0 |
| 1981 | 14 | 0 |
| 1982 | 23 | 0 |
| 1983 | 30 | 0 |
| 1984 | 18 | 0 |
| 1985 | 28 | 0 |
| 1986 | 21 | 0 |
| 1987 | 24 | 0 |
| 1988 | 25 | 0 |
| 1989 | 34 | 0 |
| 1990 | 46 | 0 |
| 1991 | 41 | 0 |
| 1992 | 47 | 0 |
| 1993 | 31 | 0 |
| 1994 | 35 | 0 |
| 1995 | 29 | 0 |
| 1996 | 32 | 0 |
| 1997 | 53 | 0 |
| 1998 | 48 | 0 |
| 1999 | 52 | 0 |
| 2000 | 62 | 0 |
| 2001 | 83 | 28 |
| 2002 | 104 | 85 |
| 2003 | 81 | 137 |
| 2004 | 79 | 156 |
| 2005 | 66 | 130 |
| 2006 | 79 | 124 |
| 2007 | 60 | 134 |
| 2008 | 77 | 110 |
| 2009 | 75 | 138 |
| 2010 | 82 | 158 |
| 2011 | 91 | 139 |
| 2012 | 111 | 144 |
| 2013 | 128 | 136 |
| 2014 | 135 | 160 |
| 2015 | 128 | 164 |
| 2016 | 138 | 152 |
| 2017 | 130 | 142 |
| 2018 | 86 | 133 |
| 2019 | 106 | 103 |
| 2020 | 73 | 108 |
| 2021 | 74 | 105 |
| 2022 | 52 | 92 |
| 2023 | 59 | 120 |
| 2024 | 52 | 117 |
| 2025 | 69 | 81 |
| 2026 | 44 | 59 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- TEAD inhibitors29 Sep 2026US 12,747,207 B2Orion Corporation
- Pyridine derivatives as TMEM16A modulators for use in the treatment of respiratory conditions29 Sep 2026US 12,747,212 B2TMEM16A Limited
- D-amphetamine compounds, compositions, and processes for making and using the same15 Sep 2026US 12,735,388 B2Zevra Therapeutics, Inc.
- Arylsulfonamides as orexin receptor agonists8 Sep 2026US 12,729,178 B2Research Triangle Institute
- Process for the preparation of 5-chloro-3-alkylsulfanyl-pyridine-2-carboxylic acid amides and carboxylates8 Oct 2026US 2026/0308124 A1Syngenta Crop Protection AG
- Heterocyclic carboxylic acid hydrazide ligand and use thereof in copper-catalyzed aryl halide coupling reaction8 Oct 2026US 2026/0308125 A1Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
- Compounds and methods of use1 Oct 2026US 2026/0297089 A1Tango Therapeutics, Inc.
- Pentamidine analogue polymorphs, formulations, and methods thereof17 Sep 2026US 2026/0274798 A1Auransa Inc.
- Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof10 Sep 2026US 2026/0263438 A1Akebia Therapeutics, Inc.
Most cited
By later US patents
- Pharmaceutical formulations for parenteral use208US 5,024,998 AUniversity of Florida · 1991
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Compositions for oral delivery of active agents159US 5,650,386 AEmisphere Technologies, Inc. · 1997
- Benzamides and related inhibitors of factor Xa155US 7,285,565 B2Millennium Pharmaceuticals, Inc. · 2007
- Polymerization of ethylene140US 5,955,555 AE. I. Du Pont de Nemours and Company · 1999